Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
SWOG Cancer Research Network
Korean Society of Hematology
Cancer Trials Ireland
Children's Oncology Group
European Organisation for Research and Treatment of Cancer - EORTC